Journal Article

FZJ-2024-06610

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Deciphering the Therapeutic Potential of Novel Pentyloxyamide-Based Class I, IIb HDAC Inhibitors against Therapy-Resistant Leukemia

Fischer, F. ; Schliehe-Diecks, J. ; Tu, J.-W. ; Gangnus, T. ; Ho, Y. L. ; Hebeis, M. ; Alves Avelar, L. A. ; Scharov, K. ; Watrin, T. ; Kemkes, M. ; Stachura, P. ; Daugs, K. ; Biermann, L. ; Kremeyer, J. ; Horstick, N. ; Span, I. ; Pandyra, A. A. ; Borkhardt, A. ; Gohlke, H.FZJ* ; Kassack, M. U. ; Burckhardt, B. B. ; Bhatia, S. (Corresponding author) ; Kurz, T. (Corresponding author)

2024
ACS Washington, DC

This record in other databases:      

Please use a persistent id in citations: doi:10.1021/acs.jmedchem.4c02024  doi:10.34734/FZJ-2024-06610

---

Contributing Institute(s):

1. Bioinformatik (IBG-4)

Research Program(s):

1. 2171 - Biological and environmental resources for sustainable use (POF4-217) (POF4-217)
2. GRK 2158 - GRK 2158: Naturstoffe und Analoga gegen Therapie-resistente Tumoren und Mikroorganismen: Neue Leitstrukturen und Wirkmechanismen (270650915) (270650915)

Appears in the scientific report 2024

---

Database coverage:
; ; BIOSIS Previews ; Biological Abstracts ; Chemical Reactions ; Clarivate Analytics Master Journal List ; Current Contents - Life Sciences ; Ebsco Academic Search ; Essential Science Indicators ; Index Chemicus ; Nationallizenz ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection

---